~~<i id='C3D31287A3'><strike id='C3D31287A3'><tt id='C3D31287A3'><pre id='C3D31287A3'></pre></tt></strike></i>~~

Home» leisure time» hotspot

hotspot

author：Wikipedia 2025-09-28 17:47:57 Page View：298

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Who is Magistrate Judge Moxila Upadhyaya in Trump's Jan. 6 case?
Next article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

knowledge

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

White House drug shortage group privately met with industry

ApatientreceivesanIVdripatahospitalinPortland,Ore.JennyKane/APWASHINGTON—AnewWhiteHousetaskfo

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

Biden praises World Series champion Astros for impact off the field during White House celebration

0:38PresidentJoeBidenholdsupajerseyasteammanageroftheHoustonAstrosDustyBakerlooksonduringanEastRoome